New gene therapy gives hope to lung cancer patients
United Cancer Research Center British efforts with pharmaceutical companies, manufacturers of drugs and the British National Health Authority to launch an experimental treatment «National Lung
system», through next summer, which represents hope for lung cancer patients in Britain to target tumors treatment specialist for each particular patient.
Treatment depends on taking a sample from a patient's tumor with lung cancer, and then analyzed by the researchers to put his map genetic mutations and genetic changes.
Then the patient is given the opportunity to address the specific treatment is being developed to target carcinoma own.
During the course of the experimental treatment, a drug is tested 14 different, and here it should be noted that clinical trials of drugs to resort to the experience of only one drug.
The head of the clinical department at the Institute of Cancer Research UK, Peter Johnson, said the dramatic developments in molecular tests means that we now know a lot about how the evolution of different types of cancer.
He added that the reason behind the fact that this is exciting for patients with lung cancer is that it is the first time that we can consider them to cancerous tumors and the development of genetic sequence of the scope of changes to the macro-molecular changes to the development of cancer.
He added: «then we can say that this treatment is that we believe will be effective for you in case that does not work chemotherapy .. So, instead of a discussion on one type of treatment, it has become our currently a full range of treatments that have started to enter experimentation stage, and in this way we hope to achieve rapid progress ».
It is expected to be the experience of various treatments on the first small group of patients, during which the researchers searching for signs of improvement, such as the increase in the percentage of survival and shrinking the cancerous tumor.
For drugs that show promising signs of progress in the fight against the disease, it will be later piloted a larger number of patients.
It is noteworthy that lung cancer is the second killer disease in Britain and much of the world, it causes the death of 42 thousand people annually.
The chief executive of the Institute of Cancer Research UK Harbul Kumar, for «Sky News», said the current experimental treatment could rephrase the search rules in the development of new drugs.
He added that the new treatment is a new and important step on the road to progress to the fight against cancer.
0 Comments